CN104159609B - 用于预防锦鲤疱疹病毒(khv)引起的疾病的重组khv和疫苗 - Google Patents
用于预防锦鲤疱疹病毒(khv)引起的疾病的重组khv和疫苗 Download PDFInfo
- Publication number
- CN104159609B CN104159609B CN201280065496.XA CN201280065496A CN104159609B CN 104159609 B CN104159609 B CN 104159609B CN 201280065496 A CN201280065496 A CN 201280065496A CN 104159609 B CN104159609 B CN 104159609B
- Authority
- CN
- China
- Prior art keywords
- khv
- gene
- koi herpesvirus
- restructuring
- live
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16041—Use of virus, viral particle or viral elements as a vector
- C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16061—Methods of inactivation or attenuation
- C12N2710/16062—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/20—Pseudochromosomes, minichrosomosomes
- C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Farming Of Fish And Shellfish (AREA)
Abstract
Description
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11196171 | 2011-12-30 | ||
EP11196171.0 | 2011-12-30 | ||
PCT/EP2012/076496 WO2013098214A1 (en) | 2011-12-30 | 2012-12-20 | A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104159609A CN104159609A (zh) | 2014-11-19 |
CN104159609B true CN104159609B (zh) | 2018-05-22 |
Family
ID=47429841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280065496.XA Active CN104159609B (zh) | 2011-12-30 | 2012-12-20 | 用于预防锦鲤疱疹病毒(khv)引起的疾病的重组khv和疫苗 |
Country Status (18)
Country | Link |
---|---|
US (2) | US20140348875A1 (zh) |
EP (1) | EP2797627B1 (zh) |
JP (3) | JP5982009B2 (zh) |
CN (1) | CN104159609B (zh) |
BR (1) | BR112014016117A2 (zh) |
HU (1) | HUE053075T2 (zh) |
IL (1) | IL232902A0 (zh) |
IN (1) | IN2014CN04655A (zh) |
MD (1) | MD4481C1 (zh) |
MX (1) | MX361408B (zh) |
PH (1) | PH12014501388A1 (zh) |
PL (1) | PL2797627T3 (zh) |
RS (1) | RS61261B1 (zh) |
RU (1) | RU2662768C2 (zh) |
SG (1) | SG11201403066TA (zh) |
TW (1) | TWI484034B (zh) |
UA (2) | UA114719C2 (zh) |
WO (1) | WO2013098214A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2662768C2 (ru) * | 2011-12-30 | 2018-07-31 | Гесвал с.а. | Рекомбинантный герпесвирус кои (khv) и вакцина для профилактики заболевания, вызываемого khv |
WO2017177071A1 (en) * | 2016-04-08 | 2017-10-12 | William Marsh Rice University | Improved galactose utilization |
RU2736472C2 (ru) * | 2016-11-18 | 2020-11-17 | Общество с ограниченной ответственностью "ЭКСИФАРМ" | Химерный белок, синтетическая днк, кодирующая указанный белок, экспрессионный вектор, штамм-продуцент синтетической днк и способ получения плазмидной днк |
CN112279897B (zh) * | 2018-11-05 | 2021-12-28 | 深圳技术大学 | 一种预防或治疗鱼类感染CyHV-2的试剂及应用 |
EP3662929A1 (en) * | 2018-12-07 | 2020-06-10 | IDT Biologika GmbH | A recombinant koi herpesvirus (khv) and a diva vaccine for preventing and/or treating a disease caused by khv |
CN110101854B (zh) * | 2019-05-14 | 2022-08-02 | 四川农业大学 | 一种鲤疱疹病毒ⅲ型疫苗及其制备方法 |
CN110468111B (zh) * | 2019-08-07 | 2022-06-17 | 西北农林科技大学 | 一种展示CyHV-2膜蛋白的重组杆状病毒及其制备方法和应用 |
CN110452926B (zh) * | 2019-08-07 | 2022-06-17 | 西北农林科技大学 | 一种展示CyHV-2膜蛋白的重组杆状病毒及其制备方法和应用 |
CN113679832A (zh) * | 2021-05-24 | 2021-11-23 | 苏州大学 | 一种利用冷冻干燥制备杆状病毒载鲤疱疹病毒ii型dna疫苗的方法 |
CN115960903B (zh) * | 2022-12-23 | 2023-09-08 | 中国水产科学研究院淡水渔业研究中心 | 一种抑制CyHV-2病毒增殖的反义RNA组、重组载体和纳米粒递送系统及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1742083A (zh) * | 2003-01-01 | 2006-03-01 | 耶路撒冷希伯来大学伊萨姆研发公司 | 对鱼进行抗病毒感染的免疫 |
CN101495636A (zh) * | 2006-04-13 | 2009-07-29 | 国立大学法人东京海洋大学 | 锦鲤疱疹病毒(khv)病用dna疫苗 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2068989T3 (es) | 1989-02-04 | 1995-05-01 | Akzo Nobel Nv | Tocoles como adyuvante en vacunas. |
DE19733364A1 (de) | 1997-08-01 | 1999-02-04 | Koszinowski Ulrich H Prof | Verfahren zur Klonierung eines großen Virusgenoms |
JP2007223913A (ja) * | 2006-02-21 | 2007-09-06 | Kyoritsu Seiyaku Kk | コイヘルペスウイルス病ワクチン |
MD20100029A2 (ro) * | 2007-08-28 | 2010-08-31 | Льежский Университет | Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) şi vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi |
DE102007041332A1 (de) * | 2007-08-31 | 2009-03-05 | Siemens Ag | Transferchuck zur Übertragung, insbesondere von Wafern |
RU2662768C2 (ru) * | 2011-12-30 | 2018-07-31 | Гесвал с.а. | Рекомбинантный герпесвирус кои (khv) и вакцина для профилактики заболевания, вызываемого khv |
-
2012
- 2012-12-20 RU RU2014131474A patent/RU2662768C2/ru active
- 2012-12-20 MX MX2014008045A patent/MX361408B/es active IP Right Grant
- 2012-12-20 JP JP2014549442A patent/JP5982009B2/ja active Active
- 2012-12-20 US US14/368,093 patent/US20140348875A1/en not_active Abandoned
- 2012-12-20 HU HUE12806062A patent/HUE053075T2/hu unknown
- 2012-12-20 RS RS20201561A patent/RS61261B1/sr unknown
- 2012-12-20 WO PCT/EP2012/076496 patent/WO2013098214A1/en active Application Filing
- 2012-12-20 CN CN201280065496.XA patent/CN104159609B/zh active Active
- 2012-12-20 UA UAA201408626A patent/UA114719C2/uk unknown
- 2012-12-20 EP EP12806062.1A patent/EP2797627B1/en active Active
- 2012-12-20 PL PL12806062T patent/PL2797627T3/pl unknown
- 2012-12-20 BR BR112014016117-8A patent/BR112014016117A2/pt not_active Application Discontinuation
- 2012-12-20 SG SG11201403066TA patent/SG11201403066TA/en unknown
- 2012-12-20 UA UAA201702576A patent/UA119786C2/uk unknown
- 2012-12-27 MD MDA20120127A patent/MD4481C1/ro not_active IP Right Cessation
- 2012-12-28 TW TW101150791A patent/TWI484034B/zh not_active IP Right Cessation
-
2014
- 2014-06-01 IL IL232902A patent/IL232902A0/en unknown
- 2014-06-18 PH PH12014501388A patent/PH12014501388A1/en unknown
- 2014-06-19 IN IN4655CHN2014 patent/IN2014CN04655A/en unknown
-
2016
- 2016-04-14 JP JP2016081363A patent/JP2016195593A/ja active Pending
- 2016-05-25 US US15/164,010 patent/US9931396B2/en active Active
-
2018
- 2018-01-11 JP JP2018002936A patent/JP2018078903A/ja not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1742083A (zh) * | 2003-01-01 | 2006-03-01 | 耶路撒冷希伯来大学伊萨姆研发公司 | 对鱼进行抗病毒感染的免疫 |
CN101495636A (zh) * | 2006-04-13 | 2009-07-29 | 国立大学法人东京海洋大学 | 锦鲤疱疹病毒(khv)病用dna疫苗 |
Non-Patent Citations (1)
Title |
---|
Cloning of the Koi Herpesvirus Genome as an Infectious Bacterial Artificial Chromosome Demonstrates That Disruption of the Thymidine Kinase Locus Induces Partial Attenuation in Cyprinus carpio koi;B. Costes等;《JOURNAL OF VIROLOGY》;20080531;第82卷(第10期);4955–4964 * |
Also Published As
Publication number | Publication date |
---|---|
RS61261B1 (sr) | 2021-01-29 |
MD4481B1 (ro) | 2017-05-31 |
MX361408B (es) | 2018-12-04 |
JP5982009B2 (ja) | 2016-08-31 |
TWI484034B (zh) | 2015-05-11 |
RU2662768C2 (ru) | 2018-07-31 |
EP2797627A1 (en) | 2014-11-05 |
CN104159609A (zh) | 2014-11-19 |
EP2797627B1 (en) | 2020-10-07 |
PH12014501388A1 (en) | 2014-09-22 |
JP2016195593A (ja) | 2016-11-24 |
US20140348875A1 (en) | 2014-11-27 |
JP2018078903A (ja) | 2018-05-24 |
IN2014CN04655A (zh) | 2015-09-18 |
IL232902A0 (en) | 2014-07-31 |
TW201333201A (zh) | 2013-08-16 |
MD20120127A2 (en) | 2013-07-31 |
JP2015503914A (ja) | 2015-02-05 |
BR112014016117A2 (pt) | 2018-09-25 |
US9931396B2 (en) | 2018-04-03 |
HUE053075T2 (hu) | 2021-06-28 |
UA114719C2 (uk) | 2017-07-25 |
MD4481C1 (ro) | 2017-12-31 |
PL2797627T3 (pl) | 2021-06-28 |
UA119786C2 (uk) | 2019-08-12 |
WO2013098214A1 (en) | 2013-07-04 |
US20170028057A1 (en) | 2017-02-02 |
RU2014131474A (ru) | 2016-02-20 |
MX2014008045A (es) | 2014-10-24 |
SG11201403066TA (en) | 2014-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104159609B (zh) | 用于预防锦鲤疱疹病毒(khv)引起的疾病的重组khv和疫苗 | |
RU2551982C2 (ru) | Способ получения поксвирусов и композиции поксвирусов | |
EP2195021B1 (en) | A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi | |
CN107815441B (zh) | 一种ⅱ型伪狂犬病毒减毒株及其制备方法和应用 | |
JP2024026075A (ja) | 改変ワクシニアベクター | |
CN113201507B (zh) | 一种重组的伪狂犬病病毒及其疫苗组合物 | |
US9493738B2 (en) | Method for producing high yield attenuated Salmonella strains | |
CN109789199B (zh) | 鸭肠炎病毒及其用途 | |
US20180208905A1 (en) | Orf7 deficient varicella virus, vaccine comprising the virus and use thereof | |
KR20170063552A (ko) | 재조합 혈청형 9 조류 아데노바이러스 벡터 형태의 백신 | |
CN109310750B (zh) | 编码传染性喉气管炎病毒和传染性法氏囊病病毒抗原的重组非致病性马立克氏病病毒构建体 | |
NO347468B1 (no) | Et modifisert Vacciniavirus Ankara (MVA) for anvendelse ved immunisering. | |
JP7387623B2 (ja) | 標的タンパク質を安定して発現できる組換えウイルス | |
RU2721575C2 (ru) | Вирус утиного энтерита и его применение | |
CN109562157A (zh) | 多价重组spv | |
EP2031065A1 (en) | A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi | |
US10201604B2 (en) | Live attenuated infectious laryngotracheitis virus (ILTV) vaccines and preparation thereof | |
CN113388641B (zh) | 一种禽4型腺病毒载体、构建方法及其减毒活疫苗和应用 | |
Rubino | Creation and characterization of VZV recombinant strain ORF7Δ in a novel RFP-ORF23 fusion BAC construct | |
CN101942418A (zh) | 狂犬病病毒Flury-LEP糖蛋白第333位氨基酸突变株 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160719 Address after: Belgium Aung San Applicant after: Gus Val AG Address before: Belgium Aung San Applicant before: University of Liege |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20141119 Assignee: NINGBO SANSHENG BIOLOGICAL TECHNOLOGY Co.,Ltd. Assignor: GESVAL S.A. Contract record no.: X2021990000218 Denomination of invention: Recombinant KHV and vaccine for prevention of diseases caused by Koi herpesvirus (KHV) Granted publication date: 20180522 License type: Exclusive License Record date: 20210413 |
|
EE01 | Entry into force of recordation of patent licensing contract |